# Ascentage Pharma Group International: Form 6-K, filed Oct 7, 2025

- Company: [Ascentage Pharma Group International](/companies/aapg.md) (CIK 2023311)
- Form: 6-K
- Filed: 2025-10-07
- Accepted by EDGAR: Oct 7, 2025, 09:15 ET
- Period: 2025-10-07
- Accession: 0001213900-25-096819
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2023311/000121390025096819/ea0260527-6k_ascentage.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2023311/000121390025096819/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2023311/000121390025096819/ea0260527-6k_ascentage.htm

Filed Oct 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-096819. Last ingested by Listed: Nov 5, 2026, 12:38 ET. No prices; not investment advice.
